Treatment response with bilateral mixed deafness and facial palsy in polyarteritis nodosa.
D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005158:Facial Paralysis / Q000209:etiology*; D034381:Hearing Loss / Q000209:etiology*; D006314:Hearing Loss, Conductive / Q000209:etiology*; D006319:Hearing Loss, Sensorineural / Q000209:etiology* / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010488:Polyarteritis Nodosa / Q000150:complications / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage
D003520:Cyclophosphamide; D011239:Prednisolone